Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Jiangsu HengRui Medicine Co., Ltd..
Real, source-linked trial activity for Jiangsu HengRui Medicine Co., Ltd.: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 27, 2026. Source-linked, daily-refreshed.
PHASE3 2PHASE2 1
Newest Jiangsu HengRui Medicine Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Th | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 56d ago | A Global Trial of Trastuzumab Rezetecan (SHR-A1811) in Combination Wit | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 61d ago | FH-006 Versus Investigator's Choice of Chemotherapy in Patients With L | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Jiangsu HengRui Medicine Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.